India gets around 68% of its raw materials -- known as active pharmaceutical ingredients (APIs) -- from China. Any disruption in that supply chain can create a major problem, especially during a pandemic.
from CNN.com - RSS Channel https://ift.tt/2Zcj98m
0 Comments